Cyclization of Hindered Fluorinated Alkenyl Radicals
J . Org. Chem., Vol. 62, No. 21, 1997 7199
(t, J ) 32 Hz), 122.65 (t, J ) 258 Hz), 124.93, 128.61, 130.81,
132.11, 137.64, 150.96, 152.12; 19F-NMR (CDCl3 ) -102.0 (dd,
J ) 37, 15 Hz); MS m/ z (%) 337 (M+, 6), 112 (100). Anal.
Calcd for C14H15F2Cl2NS: C, 49.71; H, 4.47; N, 4.14. Found:
C, 49.89; H, 4.42; N, 3.95.
Hz), -105.7 (d, J ) 238 Hz); MS m/ z (%) 351 (M+, 5), 111
(100). Anal. Calcd for C15H17Cl2F2NS: C, 51.14; H, 4.86; N,
3.98. Found: C, 51.04; H, 4.76; N, 4.19.
P h otor ea ction of 1h a n d 3 was performed as above using
1h (915 mg, 3.5 mmol) 3 (4.0 mL, ca. 40 mmol), and CH2Cl2 (4
mL) with irradiation for 5 h.
1-Me t h yle n e -2-[(2-p yr id ylt h io)m e t h yl]cycloh e xa n e
(4h ): 107 mg (14%); colorless oil; 1H-NMR (CDCl3) 1.25-1.76
(5H, m), 1.89-2.12 (2H, m), 2.24-2.48 (2H, m), 3.26 (1H, dd,
J ) 13, 8 Hz), 3.48 (1H, dd, J ) 13, 7 Hz), 4.71 (1H, s), 4.77
(1H, s), 6.96 (1H, ddd, J ) 7, 5, 1 Hz), 7.17 (1H, dt, J ) 8, 1
Hz), 7.46 (1H, ddd, J ) 8, 7, 2 Hz), 8.43 (1H, ddd, J ) 5, 2, 1
Hz).
(3a R*,4S*,7a R*)-3,3-Dich lor o-2,2-d iflu or o-4-(2-p yr id yl-
th io)p er h yd r oin d en e (6f): 195 mg (29%); colorless solid; mp
96-99 °C; 1H-NMR (500 MHz; CDCl3) 1.60-1.65 (2H, m),
1.70-1.75 (1H, m), 1.80-1.85 (1H, m), 1.89 (1H, ddd, J ) 15,
10, 5 Hz), 2.10 (1H, dddd, J ) 32, 15, 9, 6 Hz), 2.33 (1H, ddd,
J ) 19, 10, 5 Hz), 2.47-2.54 (1H, m), 2.56 (1H, ddd, J ) 19,
14, 10 Hz), 2.91 (1H, dt, J ) 8, 4 Hz), 4.69 (1H, q, J ) 4 Hz),
7.02 (1H, ddd, J ) 7, 5, 1 Hz), 7.21 (1H, dt, J ) 8, 1 Hz), 7.51
(1H, ddd, J ) 8, 5, 2 Hz), 8.48 (1H, ddd, J ) 5, 2, 1 Hz); 13C-
NMR (CDCl3) 20.29, 28.42, 29.39, 29.78 (d, J ) 6 Hz), 37.05
(dd, J ) 24, 20 Hz), 39.20, 52.31, 90.69 (dd, J ) 27, 24 Hz),
120.35, 123.59, 125.06 (dd, J ) 268, 252 Hz), 136.73, 149.87,
157.98; 19F-NMR (CDCl3) -115.2 (dd, J ) 221, 8 Hz), -95.2
(ddd, J ) 221, 32, 16 Hz); MS (CI) m/ z (%) 338 (M + H+, 100).
Anal. Calcd for C14H15Cl2F2NS: C, 49.71; H, 4.47; N, 4.14.
Found: C, 49.67; H, 4.33; N, 4.30.
(3a R*,4R*,7a S*)-3,3-Dich lor o-2,2-d iflu or o-4-[2,2-d ich lo-
r o-1,1-d iflu or o-2-(2-p yr id ylt h io)et h yl]p er h yd r oin d en e
(8f): 212 mg (22%); pale yellow solid; mp 70-78 °C; 1H-NMR
(500 MHz, CDCl3) 1.50-1.62 (2H, m), 1.63-1.67 (1H, m),
1.89-1.93 (1H, m), 2.05-2.17 (2H, m), 2.42-2.48 (2H, m), 2.63
(1H, ddd, J ) 22, 15, 10 Hz), 3.23 (1H, dd, J ) 9, 3 Hz), 3.53
(1H, ddd, J ) 22, 16, 6 Hz), 7.40 (1H, ddd, J ) 7, 5, 2 Hz),
7.79 (1H, td, J ) 7, 2 Hz), 7.88 (1H, ddd, J ) 7, 2, 1 Hz) 8.72
(1H, ddd, J ) 5, 2, 1 Hz); 13C-NMR (CDCl3) 20.41, 22.99 (dd,
J ) 5, 4 Hz), 30.30 (d, J ) 7 Hz), 30.61, 37.08 (t, J ) 21 Hz),
37.67 (dd, J ) 25, 20 Hz), 45.88 (d, J ) 6 Hz), 91.40 (dd, J )
26, 25 Hz), 94.22 (t, J ) 35 Hz), 122.43 (dd, J ) 266, 261 Hz),
124.94 (dd, J ) 268, 253 Hz), 125.11, 132.52, 137.68, 151.08,
151.96; 19F-NMR (CDCl3) -116.0 (dd, J ) 221, 10 Hz), -100.1
(dd, J ) 247, 21 Hz), -93.7 (ddd, J ) 221, 32, 20 Hz), -91.5
(dd, J ) 247, 15 Hz); MS (CI) m/ z (%) 472 (M + H+, 100).
Anal. Calcd for C16H15Cl4F4NS: C, 40.79; H, 3.21; N, 2.97.
Found: C, 40.83; H, 3.30; N, 2.83.
1-Meth ylen e-2-[2,2-diflu or o-3,3-dich lor o-3-(2-pyr idylth -
1
io)p r op yl]cycloh exa n e (5h ): 87 mg (7%); colorless oil; H-
NMR (CDCl3) 1.33-1.80 (5H, m), 1.87-1.99 (1H, m), 2.04-
2.17 (1H, m), 2.24-2.35 (1H, m), 2.35-2.56 (1H, m), 2.61-
2.68 (1H, m), 2.70-2.96 (1H, m), 4.67 (1H, s), 4.72 (1H, s), 7.39
(1H, ddd, J ) 8, 4, 1 Hz), 7.79 (1H, td, J ) 7, 2Hz), 7.88 (1H,
d, J ) 8 Hz), 8.71 (1H, d, J ) 4 Hz); 13C-NMR (CDCl2) 24.20,
28.60, 34.35 (t, J ) 23 Hz), 34.45 (d, J ) 2 Hz), 34.98, 37.39
(d, J ) 2 Hz), 94.95 (t, J ) 33Hz), 106.66, 122.72 (t, J ) 258
Hz), 124.95, 132.16, 137.65, 150.99, 151.78, 152.16; 19F-NMR
(CDCl3) -100.6 (ddd, J ) 236, 30, 12 Hz), -104.1 (ddd, J )
236, 25, 10 Hz); MS (CI) m/ z (%) 352 (M + H+, 100). Anal.
Calcd for C15H17Cl2F2NS; C, 51.14; H, 4.86; N, 3.98. Found:
C, 50.92; H, 4.85; N, 3.93.
cis-3,3-Dich lor o-2,2-d iflu or o-4a -(2-p yr id ylth io)d eca h y-
d r on a p h th a len e (7h ): 631 mg (52%); colorless solid; mp 94-
96 °C; 1H-NMR (500 MHz, CDCl3) 1.33 (1H, tt, J ) 13, 3 Hz),
1.36-1.40 (1H, m), 1.54-1.62 (2H, m), 1.86-1.89 (1H, m), 1.92
(1H, tt, J ) 13, 3 Hz), 2.00 (1H, ddd, J ) 18, 7, 4 Hz), 2.23
(1H, tq, J ) 13, 2 Hz), 2.58-2.65 (2H, m), 2.70 (1H, dt, J )
33, 14 Hz), 3.32 (1H, dd, J ) 15, 5 Hz), 3.58 (1H, dd, J ) 15,
2 Hz), 7.10 (1H, ddd, J ) 7, 4, 1 Hz), 7.30 (1H, d, J ) 7 Hz),
7.54 (1H, td, J ) 7, 2 Hz), 8.52 (1H, dd, J ) 4, 1 Hz); 13C-NMR
(CDCl3) 20.24, 22.129, 26.45, 29.57, 32.62 (dd, J ) 23, 21 Hz),
32.64 (d, J ) 2 Hz), 54.52, 55.82, 85.81 (dd, J ) 29, 24 Hz),
119.49 (dd, J ) 256, 247 Hz), 121.58, 127.48, 136.82, 150.22,
157.35; 19F-NMR (CDCl3) -102.6 (ddd, J ) 236, 32, 8 Hz),
-107.4 (d, J ) 236 Hz); MS (CI) m/ z (%) 352 (M + H+, 100).
Anal. Calcd for C15H17Cl2F2NS; C, 51.14; H, 4.86; N, 3.98.
Found: C, 51.13; H, 4.96; N, 4.01.
P h otor ea ction of 1g a n d 3 was performed as above using
1g (790 mg, 3.0 mmol), which contains 5% of cyclohexylidene
isomer 10, 3 (3.0 mL, ca. 30 mmol), and CH2Cl2 (3 mL) with
irradiation for 5 h.
P h otor ea ction of 2 a n d 3 was performed as above using
2 (592 mg, 2.65 mmol), 3 (2.5 mL, ca. 25 mmol), and CH2Cl2
(2.5 mL) with irradiation for 3 h.
1-[2-(2-P yr id ylt h io)et h yl]cycloh exen e (4g): 152 mg
(23%); pale yellow oil; 1H-NMR (CDCl3) 1.50-1.68 (4H, m),
1.96-2.02 (4H, m), 2.33 (2H, t, J ) 7.6 Hz), 3.21-3.29 (2H,
m), 5.51 (1H, m), 6.96 (1H, ddd, J ) 7, 5, 1 Hz), 7.17 (1H, dt,
J ) 8, 1 Hz), 7.46 (1H, dt, J ) 8, 7, 2 Hz), 8.426 (1H, ddd, J )
5, 2, 1 Hz).
2:1 Mixt u r e of 1-[4,4-d ich lor o-3,3-d iflu or o-4-(2-p y-
r id ylth io)bu tyl]cycloh exen e (5g) a n d [4,4-d ich lor o-3,3-
d iflu or o4-(2-p yr id ylt h io)b u t ylid en e]cycloh exa n e:13 84
mg (8%: 5g; 5%); pale yellow oil; 1H-NMR (CDCl3) 1.53-1.70
(5.33H, m), 1.91-2.04 (2.67H, m), 2.16-2.29 (2.67H, m), 2.42-
2.68 (1.33H, m), 3.20 (0.67H, td, J ) 18, 7 Hz), 5.20 (0.33H,
tt, J ) 7, 1 Hz), 5.50 (0.67H, m), 7.35-7.43 (1H, m), 7.74-
7.83 (1H, m), 7.88 (1H, dt, J ) 7, 1 Hz), 8.69-8.73 (1H, m);
19F-NMR (CDCl3) -104.5 (t, J ) 19 Hz, 0.67F), -102.9 (t, J )
18 Hz; 0.33F); GC-MS m/ z (%) 5g; 351 (M+, 5),111 (100). Anal.
Calcd for C15H17Cl2F2NS: C, 51.14; H, 4.86; N, 3.98. Found:
C, 51.21; H, 4.68; N, 4.28.
1,1-Dich lor o-2,2-d iflu or o-4a -(2-p yr id ylt h io)d e ca h y-
d r on a p h th a len e (7g): 569 mg (54%); colorless solid; mp 76-
98 °C; 1H-NMR (500 MHz, CDCl3) 1.161 (1H, ddd, J ) 14, 13,
4 Hz), 1.36-1.45 (2H, m), 1.64 (2H, t, J ) 18 Hz), 1.91-2.03
(2H, m), 2.11-2.21 (2H, m), 2.26 (2H, br d, J ) 25 Hz), 3.01
(1H, dd, J ) 7, 4 Hz), 3.04-3.06 (1H, m), 7.10 (1H, ddd, J )
8, 5, 1 Hz), 7.40 (1H, d, J ) 8 Hz), 7.53 (1H, td, J ) 8, 2 Hz),
8.48 (1H, dd, J ) 5, 1 Hz); recognizable minor peaks of the
stereoisomer, 3.07 (ddd, J ) 8, 4, 1 Hz), 3.13 (dd, J ) 16, 4
Hz), 7.32 (d, J ) 8 Hz), 8.51 (dd, J ) 5, 1 Hz); 13C-NMR (CDCl3)
21.28, 22.73, 25.94, 27.83 (dd, J ) 24, 22 Hz), 34.39 (d, J ) 9
Hz), 57.87, 58.54, 90.85 (d, J ) 29, 23 Hz), 119.72 (d, J ) 258,
246 Hz), 121.95, 129.00, 136.99, 150.01, 156.93; recognizable
minor peaks of the stereoisomer, 21.05, 38.07, 56.31, 122.28,
128.47, 150.20; 19F-NMR (CDCl3) -100.6 (ddd, J ) 238, 32, 7
4-(2-P yr id ylth io)-1-p en ten e (14): 34 mg (7%); colorless
1
oil; H-NMR (CDCl3) 1.82 (2H, quintet, J ) 7 Hz); 2.15-2.28
(2H, m), 3.19 (2H, t, J ) 7 Hz), 4.96-5.12 (2H, m), 5.83 (1H,
ddt, J ) 17, 10, 7Hz), 6.97 (1H, ddd, J ) 7, 5, 1 Hz), 7.18 (1H,
dt, J ) 8, 1 Hz), 7.48 (1H, ddd, J ) 8, 7, 2 Hz), 8.43 (1H, ddd,
J ) 5, 2, 1 Hz).
6,6-Dich lor o-5,5-d iflu or o-6-(2-p yr id ylt h io)-1-h ep t en e
(15): colorless oil; 408 mg (49%); 1H-NMR (CDCl3) 1.71-1.83
(2H, m), 2.32-2.60 (2H, m), 4.99-5.13 (2H, m), 5.12 (2H, br
q, J ) 7 Hz), 5.82 (1H, ddt, J ) 17, 10, 7 Hz), 7.39 (1H, ddd,
J ) 8, 5, 1 Hz), 7.79 (1H, td, J ) 8, 2 Hz), 7.88 (1H, ddd, J )
8, 1, 1 Hz), 8.705 (1H, ddd, J ) 5, 2, 1 Hz); 13C-NMR (CDCl3)
20.85 (t, J ) 3 Hz), 31.52 (t, J ) 24 Hz), 33.10, 94.58 (t, J )
33 Hz), 115.95, 122.45 (t, J ) 256 Hz), 124.94, 137.64, 137.87,
150.97, 152.11; 19F-NMR (CDCl3) -103.9 (t, J ) 19 Hz); MS
(CI) 312 (M + H+, 100). Anal. Calcd for C12H13Cl2F2NS: C,
46.17; H, 4.20; N, 4.49. Found: C, 46.27; H, 4.20; N, 4.38.
2,2-Dich lor o-1,1-d iflu or o-3-[(2-p yr id ylth io)m eth yl]cy-
cloh exa n e (16): 122mg (15%); colorless oil; 1H-NMR (CDCl3)
1.36-1.85 (3H, m), 2.07-2.58 (4H, m) 3.141 (1H, dd, J ) 14,
10, 1 Hz), 4.02 (1H, dd, J ) 14, 3, 1 Hz), 7.00 (1H, ddd, J ) 7,
5, 1 Hz), 7.21 (1H, dt, J ) 8, 1 Hz), 7.50 (1H, ddd, J ) 8, 7, 2
Hz), 8.45 (1H, ddd, J ) 5, 2, 1 Hz); 13C-NMR (CDCl3) 20.13
(dd, J ) 7, 3 Hz), 26.90, 30.58 (t, J ) 22 Hz), 30.71, 49.80,
92.69 (dd, J ) 28, 24 Hz), 120.04 (dd, J ) 264, 245 Hz), 120.03,
122.32, 136.47, 149.99, 158.49; 19F-NMR (CDCl3) -105.0 (m);
MS m/z (%) 311 (M+, 100). Anal. Calcd for C12H13Cl2F2NS:
C, 46.17; H, 4.20; N, 4.49. Found: C, 46.45; H, 4.43; N, 4.44.
2,2-Dich lor o-1,1-d iflu or o-3-[3,3-d ich lor o-2,2-d iflu or o-
3-(2-p yr id ylth io)p r op yl]cycloh exa n e (17): 168 mg (18%);